ClinicalMetric / Countries / Israel / pseudotumor cerebri
← 🇮🇱 Israel Trials
🇮🇱 Israel Country × Condition

pseudotumor cerebri Clinical Trials in Israel

Active clinical trials for pseudotumor cerebri with research sites in Israel. All data sourced live from ClinicalTrials.gov — updated daily.

Active Trials: 1 // Recruiting: 1 // Updated: Daily
Total Trials
1
Recruiting Now
1
Country
🇮🇱 Israel

Active Trials in Israel (1)

NCT03304314
Recruiting

Multifocal Chromatic Pupilloperimetry in Patients With Pseudotumor Cerebri and Healthy Subjects.

Enrollment
100 pts
Country
🇮🇱 Israel
Sheba Medical Center
View Trial →

Frequently Asked Questions

How many pseudotumor cerebri clinical trials are active in Israel?
There are currently 1 active clinical trials for pseudotumor cerebri with sites in Israel, of which 1 are actively recruiting patients.
How can I join a pseudotumor cerebri clinical trial in Israel?
To join a pseudotumor cerebri clinical trial in Israel, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Israel directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are pseudotumor cerebri trials in Israel?
Active pseudotumor cerebri trials in Israel span multiple phases. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
Browse More
All Israel Trials → Global pseudotumor cerebri Trials → All Countries → All Trials →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology